Cytokine pathways and joint inflammation in rheumatoid arthritis

N Engl J Med. 2001 Mar 22;344(12):907-16. doi: 10.1056/NEJM200103223441207.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antibodies, Monoclonal / therapeutic use
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology*
  • Cytokines / antagonists & inhibitors*
  • Cytokines / metabolism
  • Cytokines / physiology*
  • Cytokines / therapeutic use
  • Etanercept
  • Humans
  • Immunoglobulin G / therapeutic use
  • Inflammation / immunology
  • Infliximab
  • Receptors, Cytokine / antagonists & inhibitors
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Signal Transduction

Substances

  • Antibodies, Monoclonal
  • Antirheumatic Agents
  • Cytokines
  • Immunoglobulin G
  • Receptors, Cytokine
  • Receptors, Tumor Necrosis Factor
  • Infliximab
  • Etanercept